UCB to offer minimum 150 mln euros of 5-year bonds
BRUSSELS, Oct 23 (Reuters) - Belgian pharmaceutical group UCB (UCB.BR) said on Friday it would offer a minimum of 150 million euros ($225 million) in five-year, fixed-rate bonds via a retail public offering in Belgium and Luxembourg.
The issue price is set at 101.875 percent of the nominal value of each bond with a coupon of 5.75 percent per year and a gross yield of 5.31 percent per year, UCB said in a statement.
UCB, a central nervous system and immunology specialist, said it would use the net proceeds for general corporate purposes.
The subscription period will run from Oct. 26 to Nov. 25 and the payment date is Nov. 27, the company said.
BNP Paribas Fortis, ING (ING.AS) and KBC Bank (KBC.BR) are lead managers for the transaction. (Reporting by Dale Hudson)









